Latest News for: pacap

Edit

Slate Medicines Launches with $130 Million Series A Financing to Advance Anti-PACAP Therapies for the ...

The Galveston Daily News 24 Feb 2026
RALEIGH, N.C.--(BUSINESS WIRE)--Feb 24, 2026-- ....
Edit

Slate Medicines Launches with $130 Million Series A Financing to Advance Anti-PACAP Therapies for the Prevention of Migraine and Other Headache Disorders

Pharmiweb 24 Feb 2026
PACAP (pituitary adenylate cyclase-activating polypeptide) is an emerging, clinically validated target for the prevention of migraines and potentially other headache disorders ... PACAP has emerged as a ...
Edit

Lundbeck announces positive phase IIb top-line results with bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention

Pharmiweb 12 Feb 2026
These data underline Lundbeck’s ambition to deliver the first PACAP targeting option in migraine prevention ... polypeptide (PACAP), a neuropeptide implicated in migraine pathophysiology.
  • 1

Article Search

tools
×
×
×
×